ATE476529T1 - Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapie - Google Patents
Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapieInfo
- Publication number
- ATE476529T1 ATE476529T1 AT06754554T AT06754554T ATE476529T1 AT E476529 T1 ATE476529 T1 AT E476529T1 AT 06754554 T AT06754554 T AT 06754554T AT 06754554 T AT06754554 T AT 06754554T AT E476529 T1 ATE476529 T1 AT E476529T1
- Authority
- AT
- Austria
- Prior art keywords
- predicting
- cancer therapy
- immediate response
- monitoring
- differentially expressed
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05014891 | 2005-07-08 | ||
| PCT/EP2006/006114 WO2007006408A2 (en) | 2005-07-08 | 2006-06-24 | Methods and kits for predicting and monitoring direct response to cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE476529T1 true ATE476529T1 (de) | 2010-08-15 |
Family
ID=37637515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06754554T ATE476529T1 (de) | 2005-07-08 | 2006-06-24 | Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapie |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090203533A1 (de) |
| EP (1) | EP1904645B1 (de) |
| AT (1) | ATE476529T1 (de) |
| DE (1) | DE602006015966D1 (de) |
| WO (1) | WO2007006408A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2036988A1 (de) * | 2007-09-12 | 2009-03-18 | Siemens Healthcare Diagnostics GmbH | Verfahren zur Vorhersage des Ansprechens eines Tumors auf einen chemotherapeutischen Wirkstoff bei einer Patientin, die unter einer rekurrenten gynäkologischen Krebserkrankung leidet oder Gefahr läuft, eine solche zu entwickeln |
| US9771618B2 (en) * | 2009-08-19 | 2017-09-26 | Bioarray Genetics, Inc. | Methods for treating breast cancer |
| CA2778226A1 (en) * | 2009-10-09 | 2011-04-14 | Carolyn Slupsky | Methods for diagnosis, treatment and monitoring of patient health using metabolomics |
| GB0922085D0 (en) * | 2009-12-17 | 2010-02-03 | Cambridge Entpr Ltd | Cancer diagnosis and treatment |
| EP2542696B1 (de) | 2010-03-01 | 2016-09-28 | Caris Life Sciences Switzerland Holdings GmbH | Theranostik-biomarker |
| JP2013526852A (ja) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
| WO2011153545A2 (en) * | 2010-06-04 | 2011-12-08 | Bioarray Therapeutics, Inc. | Gene expression signature as a predictor of chemotherapeutic response in breast cancer |
| KR20140067001A (ko) * | 2011-08-08 | 2014-06-03 | 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. | 생물지표 조성물 및 방법 |
| EP2883053A2 (de) * | 2012-08-08 | 2015-06-17 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Verfahren zur beurteilung der disposition eines krebspatienten zu einer reaktion auf eine therapie |
| WO2014052921A2 (en) * | 2012-09-27 | 2014-04-03 | University Of Utah Research Foundation | Patient health record similarity measure |
| CN109069426B (zh) | 2015-12-14 | 2021-10-29 | X4 制药有限公司 | 治疗癌症的方法 |
| CA3008279A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| WO2017112894A1 (en) | 2015-12-22 | 2017-06-29 | X4 Pharmaceuticals, Inc. | Methods for treating immunodeficiency disease |
| CA3019394A1 (en) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| CN109640988A (zh) | 2016-06-21 | 2019-04-16 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| EP3472129A4 (de) | 2016-06-21 | 2019-12-04 | X4 Pharmaceuticals, Inc. | Cxcr4-inhibitoren und verwendungen davon |
| ES2870920T3 (es) | 2016-06-21 | 2021-10-28 | X4 Pharmaceuticals Inc | Inhibidores de CXCR4 y usos de los mismos |
| CN107119112B (zh) * | 2017-03-30 | 2020-06-30 | 中山大学肿瘤防治中心 | 一种检测肿瘤代谢通路基因表达的引物组、pcr芯片及其应用 |
| JP2021502071A (ja) * | 2017-11-07 | 2021-01-28 | エックス４ ファーマシューティカルズ， インコーポレイテッド | がんバイオマーカーおよびその使用方法 |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| CA3171250A1 (en) | 2020-03-10 | 2021-09-16 | E. Lynne KELLEY | Methods for treating neutropenia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040101855A1 (en) * | 2002-11-22 | 2004-05-27 | Isis Pharmaceuticals Inc. | Modulation of PPAR binding protein expression |
| EP1365034A3 (de) * | 2002-05-21 | 2004-02-18 | Bayer HealthCare AG | Verfahren und Zusammensetzungen zur Vorhersage, Diagnose, Prognose, Prävention und Behandlung von malignen Tumoren |
| JP2005000056A (ja) * | 2003-06-11 | 2005-01-06 | Sumitomo Pharmaceut Co Ltd | ホルモン依存性癌疾患マーカー及びその利用 |
| ATE403755T1 (de) * | 2003-08-28 | 2008-08-15 | Ipsogen | Identifizierung einer erbb2- genexpressionssignatur bei brustkrebs |
-
2006
- 2006-06-24 AT AT06754554T patent/ATE476529T1/de not_active IP Right Cessation
- 2006-06-24 EP EP06754554A patent/EP1904645B1/de not_active Not-in-force
- 2006-06-24 WO PCT/EP2006/006114 patent/WO2007006408A2/en not_active Ceased
- 2006-06-24 US US11/988,500 patent/US20090203533A1/en not_active Abandoned
- 2006-06-24 DE DE602006015966T patent/DE602006015966D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007006408A2 (en) | 2007-01-18 |
| DE602006015966D1 (de) | 2010-09-16 |
| EP1904645B1 (de) | 2010-08-04 |
| US20090203533A1 (en) | 2009-08-13 |
| EP1904645A2 (de) | 2008-04-02 |
| WO2007006408A3 (en) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE476529T1 (de) | Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapie | |
| EP1522594A3 (de) | Verfahren und kit zur untersuchung von krebs | |
| MX2009012722A (es) | Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama. | |
| WO2007015947A3 (en) | Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies | |
| WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
| PH12015501744B1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| WO2003042661A3 (en) | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer | |
| PT1581812E (pt) | Composições e métodos para diagnóstico e tratamento de cancros do cólon | |
| EP3299387A3 (de) | Identifizierung von tumorassoziierten markern für diagnose und therapie | |
| WO2007016548A3 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
| ATE470723T1 (de) | Genexpressionsmarker für die prognose von brustkrebs | |
| EP1365034A3 (de) | Verfahren und Zusammensetzungen zur Vorhersage, Diagnose, Prognose, Prävention und Behandlung von malignen Tumoren | |
| WO2007109236A3 (en) | Microrna fingerprints during human megakaryocytopoiesis | |
| MX2009012625A (es) | Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21. | |
| WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2005123993A8 (en) | Phage microarray profiling of the humoral response to disease | |
| MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
| WO2005001092A3 (en) | Compositions and methods for diagnosing and treating cancers | |
| WO2005119260A3 (en) | Methods for predicting and monitoring response to cancer therapy | |
| WO2003065006A3 (en) | Methods and compositions for treating cancer | |
| MX2009005941A (es) | Ensayos de diagnostico complementario para terapia de cancer. | |
| WO2007150044A3 (en) | Genetic models for stratification of cancer risk | |
| WO2008060945A3 (en) | Diagnosis and treatment of breast cancer | |
| WO2001071357A3 (en) | Diagnosis and treatment of breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |